BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11880664)

  • 1. Olympics 2000: preparing to respond to bioterrorism.
    Hauer J
    Public Health Rep; 2001; 116 Suppl 2(Suppl 2):19-22. PubMed ID: 11880664
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing the bioweapons threat: international collaboration efforts.
    Eitzen EM
    Public Health Rep; 2001; 116 Suppl 2(Suppl 2):17-8. PubMed ID: 11880663
    [No Abstract]   [Full Text] [Related]  

  • 3. National leadership in confronting bioterrorism: 1.
    Hamre JJ
    Public Health Rep; 2001; 116 Suppl 2(Suppl 2):112-5. PubMed ID: 11880683
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioterrorism, public health, and civil liberties.
    Annas GJ
    N Engl J Med; 2002 Apr; 346(17):1337-42. PubMed ID: 11973377
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioterrorism: an overview.
    Peralta LA
    Semin Perioper Nurs; 2001 Oct; 10(4):167-74. PubMed ID: 15129614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and chemical bioterrorism agents.
    Porche DJ
    J Assoc Nurses AIDS Care; 2002; 13(5):57-64. PubMed ID: 12369391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state of biopreparedness: lessons from leaders, proposals for progress.
    Franco C; Hansen MB
    Biosecur Bioterror; 2010 Dec; 8(4):379-84. PubMed ID: 21142766
    [No Abstract]   [Full Text] [Related]  

  • 8. BRIEF REPORT: recent progress in biodefense countermeasure development.
    Mair M
    Biosecur Bioterror; 2005; 3(4):280-5. PubMed ID: 16392161
    [No Abstract]   [Full Text] [Related]  

  • 9. The problem of biological weapons: next steps for the nation.
    O'Toole T
    Public Health Rep; 2001; 116 Suppl 2(Suppl 2):108-11. PubMed ID: 11880682
    [No Abstract]   [Full Text] [Related]  

  • 10. A shocking biodefense editorial.
    Vanderwagen WC
    Nat Biotechnol; 2007 Oct; 25(10):1083; author reply 1083-4. PubMed ID: 17921983
    [No Abstract]   [Full Text] [Related]  

  • 11. US biodefense--shocking and awful.
    Nat Biotechnol; 2007 Jun; 25(6):603. PubMed ID: 17557081
    [No Abstract]   [Full Text] [Related]  

  • 12. Olympics' public health surveillance scheme will be retained after games, agency says.
    Gulland A
    BMJ; 2012 May; 344():e3620. PubMed ID: 22623640
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioterrorism: what can we do?
    Beale AJ
    J R Soc Med; 2002 Oct; 95(10):479-80. PubMed ID: 12356966
    [No Abstract]   [Full Text] [Related]  

  • 14. Legal issues surrounding public health emergencies.
    Fidler DP
    Public Health Rep; 2001; 116 Suppl 2(Suppl 2):79-86. PubMed ID: 11880678
    [No Abstract]   [Full Text] [Related]  

  • 15. Biodefense: who's in charge?
    Sutton V
    Health Matrix Clevel; 2003; 13(1):117-58. PubMed ID: 14569660
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations from the Top Off exercise.
    Inglesby TV
    Public Health Rep; 2001; 116 Suppl 2(Suppl 2):64-8. PubMed ID: 11880675
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioterrorism and the vital role of family physicians.
    Harris MD; Yeskey K
    Am Fam Physician; 2011 Jul; 84(1):18, 20. PubMed ID: 21766751
    [No Abstract]   [Full Text] [Related]  

  • 18. Combating bioterrorism with bioengineering.
    Laxminarayan S; Kun LG
    IEEE Eng Med Biol Mag; 2002; 21(5):21, 23-7. PubMed ID: 12405054
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological and chemical terrorism defense: a view from the "front lines" of public health.
    Henretig F
    Am J Public Health; 2001 May; 91(5):718-20. PubMed ID: 11344878
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemic response scenario: decision making in a time of plague.
    O'Toole T; Inglesby TV
    Public Health Rep; 2001; 116 Suppl 2(Suppl 2):92-103. PubMed ID: 11880680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.